Category Archives: EZ 60 – Medical

A2 Milk – The Future of Dairy

By Dr. Lim Ban Keong, D.V.M (UPM)GM of Rhone Ma Holdings Bhd

The ruminant industry in Malaysia only started taking off over the last ten years with many participants being small farmers. To help them out, we plan to share our combined expertise and technological knowhows for dairy farming and milk production with other farmers and other interested parties,”  – said Dr. Lim Ban Keong


There’s nothing better than a splash of milk in your morning coffee for the important nutrients for our body. However, sometimes consuming milk and milk products might result in tummy problems. If that happens, it’s time to try A2 milk.

Tummy problems from milk may not necessarily be due to lactose intolerance or trouble digesting lactose sugar in milk. Recent research suggests that a less-known protein, A1, may be one of the culprits. A1 produces a protein fragment known as Beta-casomorphin-7 (BCM-7) during digestion which triggers tummy discomfort and symptoms similar to those with lactose intolerance.

There are 2 kinds of proteins in milk: A1 and A2. While most cows’ milk contains both, A2A2 cows produce only A2 protein, which results in A2 milk.

Rhone Ma Holdings Berhad, a homegrown end-to-end animal health solutions provider, introduces the A2 milk to the local market through its acquisition of 49% interests each in three livestock companies in February 2020. The Group has teamed up with One Lazuli Sdn. Bhd., Nor Lazuli Nutrition Sdn. Bhd. and Nor Livestock Farm Sdn. Bhd. in order to expand into the dairy farming business.

As a first step, the Group and its partners injected RM3 million capital in Nor Livestock Farm Sdn. Bhd. who operates a 6-acre dairy farm in Batang Kali, Selangor which currently house more than 160 A2A2 Holstein cattle. The Group expects to further expand the herd to 500 heads as they are expecting around 90 more female cows to be born in a few months’ time. In addition, they are also planning to import another batch of 100 impregnated cows in 2021. The farm’s milk production currently averages 12,000 litres/month and soon the farm is expected to produce approximately 65,000 litres/month. 

The Group’s shift into the ruminant sector is part and parcel of its responsibilities as a key industry player to further develop the local ruminant industry. Rhone Ma, a proponent of the Total Solutions Programme (TSP) which allows customers the flexibility to customise the animal health services and animal health products to form their desired animal health solution, has pledged to work together with local dairy farmers to support them and establish more dairy farms in the country in line with the government’s heed to stimulate the industry. 

“The ruminant industry in Malaysia only started taking off over the last ten years with many participants being small farmers. To help them out, we plan to share our combined expertise and technological knowhows for dairy farming and milk production with other farmers and other interested parties,” said Dr. Lim Ban Keong, Managing Director of Rhone Ma Holdings Berhad.

“This will also include advocating the use of Milk Boosta the premium cattle feed that was specially formulated to induce energy for maximum milk production for cattle in a tropical climate. The combination of Milk Boosta and Alfalfa Hay and some kind of supplements also helps to reduce heat stress,” added Qasem Alhasan, Managing Director of Nor Livestock Farm Sdn. Bhd.

With the establishment of more farms, the Group will not only be able to encourage their peers to thrive in the industry but also address the issue of fresh milk insufficiency in Malaysia head on. On top of that, as consumers become more health conscious and discerning in their food consumption, the Group and its partners envisage a big future for fresh A2 milk in the local market.

reflections on healthcare here & beyond

Bryan Lin Boon Diann
Chief Executive Officer of Sunway Medical Centre


2020 has brought upon a new wave of change to people everywhere – from wearing a face mask in public areas, social distancing, practising good personal hygiene at all times to working and studying at home. 

Likewise, the hospital landscape has altered due to the unprecedented arrival of the COVID-19 pandemic. Today, patients can meet their doctors from the comforts of their homes through virtual clinics, evolving the way hospitals operate as digitisation becomes the norm. 

The pandemic has effectively changed the way businesses are run and for healthcare institutions like Sunway Medical Centre, we need to be innovative. We were the first tertiary hospital to establish the telemedicine service at the start of the pandemic, and this is one of the ways that has transformed the way we support care outside of our facility. 

We have made healthcare more accessible by extending services such as medicine delivery, nursing care, diabetes care, wound care, physiotherapy and phlebotomy to homes through our personalised, mobile healthcare services and home nursing under Sunway Home Healthcare (formerly known as SunMed@Home). 

We have also set up a Telemedicine Command Centre which facilitates referrals for patients with medical emergencies to the hospital. This will provide better patient experience journey and peace of mind during their times of need. This project is likely the first in the country and will be another game changer in the clinical landscape.

The ultimate goal is to improve patient value, and the only way the healthcare industry will achieve this is by digitalising healthcare, leveraging on artificial intelligence, telemedicine, Internet of Things (IoT) and other digital platforms to propel it to the next level. Robotics and automation will also be vital in improving overall service delivery and customer experience while enabling more personalised medical care. 

We need to demonstrate greater value in the healthcare system in this challenging time while continuing to care for patients requiring multispeciality and multidisciplinary care services and/or complex technologies. 

Setting up new and advanced quarternary service offerings like bone marrow transplant, renal transplant and paediatric cardiac surgery has also set Sunway Medical Centre apart in the market. The hospital is also focused on Women & Children Services and Acute Services to ensure that communities are well taken care of. 

As the industry grows, the requirement for highly-skilled, professional talent will also increase. 

Healthcare providers like us will need to continue developing a sustainable talent pipeline, while strengthening the existing talent pool with strategic hires, retention initiatives and continued employee training and development.

While diseases will never be completely eliminated, through science, data and technology, we will be able to identify it earlier, intervene proactively and better understand its progression to help consumers more effectively and actively sustain their wellbeing. 

Personalised medicine will progress and as researchers find out more about the particular genetic makeup of diseases, we will be able to give specific drugs to target it. And by 2030, healthcare will be centred on patients empowered to prevent diseases rather than seek treatment. They will receive personalised health solutions in ways that are integrated seamlessly into their daily lives. 

In short, healthcare providers need to change accordingly in order to forge ahead. As the rate of change in healthcare is accelerating, healthcare providers must harness the forces of driving transformation and use them to its advantage and in this case, growth, innovation and diversification.